An attenuated strain of Listeria monocytogenes expressing the pancreatic tumor-associated antigen mesothelin, in combination with GVAX, a vaccine produced from allogeneic whole pancreatic cancer cells expressing granulocyte-macrophage colony-stimulating factor (GM-CSF), has shown a survival benefit in patients [26–28]. Here, CSF2 is linked to neoplasm.